Up And Down The Ladder: Job Changes
Make a commentBy Ed Silverman // August 15th, 2007 // 7:55 am
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Here are some of the latest moves…
DaVita appointed Paul Diaz to its board of directors;
BioCryst Pharma hired Elliott Berger as senior vp of regulatory affairs;
Bradmer Pharma promoted Alan Ezrin to ceo from coo;
Medivation appointed Robert Elfont as vp of clinical development;
Neurotech Pharma named Richard Small vp and chief financial officer;
MAP Pharmaceuticals promoted Steve Shrewsbury to chief medical officer;
Seahorse Bioscience elected Joe Keegan to its board;
Cytochroma hired Joel Melnick as vp of clinical and regulatory affairs.
PPD promoted Susan Atkinson to senior vp of global biostatistics and data management;
Hat tip to Pharmaceutical Executive